Latest Signals
FDA: Amerisource Health Services LLC — Class II
Amerisource Health Services faces a Class II recall for oxycodone blister pack defects, creating diversion risks for controlled substances. This could trigger DEA scrutiny and supply chain disruptions
FDA: F.H. INVESTMENTS, Inc. (dba Asteria Health) — Class II
Third Asteria Health testosterone recall reveals contamination issues across multiple dosage strengths. This pattern indicates serious manufacturing deficiencies requiring comprehensive corrective act
FDA: F.H. INVESTMENTS, Inc. (dba Asteria Health) — Class II
Fourth Asteria Health recall extends to estradiol pellets, confirming cross-product contamination risks. This could disrupt hormone replacement therapy markets and increase regulatory pressure on comp
27 more signals available today
Get all signals delivered instantly via Telegram the moment they fire. Real-time alerts for weather mispricings, FDA decisions, SEC filings, and government contracts.
Subscribe for Real-Time AlertsSignal Categories
weather
57 signals
finance
28 signals
healthcare
21 signals
How It Works
1. Fetch
Every 3 hours, we pull fresh data from NOAA, FDA, SEC EDGAR, SAM.gov, and USDA — all free public APIs.
2. Analyze
AI batch-processes the raw data into actionable signals with confidence scores and market implications.
3. Deliver
Free users see top signals here. Premium subscribers get every signal via Telegram the instant it fires.